» Authors » Rolf-Markus Szeimies

Rolf-Markus Szeimies

Explore the profile of Rolf-Markus Szeimies including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 102
Citations 1840
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Philipp-Dormston W, Bruckner M, Hoffmann M, Bae M, Franken J, Grossmann B, et al.
Br J Dermatol . 2024 Nov; 192(3):510-519. PMID: 39509708
Background: Artificial daylight photodynamic therapy (ADL-PDT) is an alternative, all-year applicable, nearly painless treatment approach for actinic keratosis (AK) with comparable effectiveness to daylight or conventional PDT. At the time...
2.
Karrer S, Unger P, Spindler N, Szeimies R, Bosserhoff A, Berneburg M, et al.
Int J Mol Sci . 2024 Oct; 25(19). PMID: 39409136
Actinic keratosis (AK) is characterized by a reddish or occasionally skin-toned rough patch on sun-damaged skin, and it is regarded as a precursor to squamous cell carcinoma (SCC). Photodynamic therapy...
3.
Balakirski G, Lehmann P, Szeimies R, Hofmann S
J Dtsch Dermatol Ges . 2024 Sep; 22(12):1651-1662. PMID: 39226531
Photodynamic therapy (PDT) is internationally established as an approved treatment option for in situ forms of keratinocytic skin cancer (actinic keratoses, Bowen's disease, basal cell carcinoma). For these indications, there...
4.
Ulrich M, Reinhold U, Dominicus R, Aschoff R, Szeimies R, Schaning R, et al.
Photodiagnosis Photodyn Ther . 2024 Jul; 49:104280. PMID: 39002836
Background: Acral actinic keratosis (AK) lesions are considered difficult to treat, and published data for photodynamic therapy (PDT) on these lesions is limited. Thus, we evaluated sustained efficacy, safety, and...
5.
Szeimies R, Ulrich C, Ferrandiz-Pulido C, Hofbauer G, Lear J, Lebbe C, et al.
Dermatol Ther (Heidelb) . 2024 Jun; 14(7):1739-1753. PMID: 38902589
Actinic keratosis (AK) is an intraepithelial condition characterized by the development of scaly, erythematous lesions after repeated exposure to ultraviolet radiation. Significant immunosuppression is a risk factor for the development...
6.
Morton C, Szeimies R, Braathen L
Eur J Dermatol . 2024 Feb; 33(5):467-473. PMID: 38297922
This article reviews the 2022 European Society for Photodynamic Therapy (Euro-PDT) Annual Congress. PDT has been investigated for the treatment of a broad number of oncologic, infectious and inflammatory indications....
7.
8.
9.
10.
Leiter U, Heppt M, Steeb T, Alter M, Amaral T, Bauer A, et al.
J Dtsch Dermatol Ges . 2023 Oct; 21(11):1422-1433. PMID: 37840404
Actinic keratosis (AK) are common lesions in light-skinned individuals that can potentially progress to cutaneous squamous cell carcinoma (cSCC). Both conditions may be associated with significant morbidity and constitute a...